Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
LIFE enters the final stretch before its November 3 earnings with the Street divided, borrow conditions loose, and short sellers who doubled positions in a month now quietly trimming.
The most important development this week is a rating change from a bellwether firm. JP Morgan downgraded Ethos Technologies to Neutral on October 1, with analyst Pablo Singzon holding his $37 target unchanged. That move is significant context: just weeks after a cluster of firms lifted targets following the August earnings beat, one of the louder bulls on the stock has moved to the sidelines. The remaining consensus sits at outperform-leaning, with two Outperform/Overweight ratings and one Hold, but JP Morgan's retreat caps the near-term upside case at the current target band. At $34.92, the stock trades about 6% below that $37 level, a narrower cushion than bulls would like heading into a binary event.
The short-interest story is striking for its speed rather than its size. Shorts roughly doubled between early September and late September, climbing from around 720,000 shares to over 2.24 million. That is a 133% jump on the month. Since then, the position has pulled back modestly, down about 5% on the week to 2.13 million shares. Float data is unavailable, so a precise percentage-of-float figure cannot be calculated, but the absolute level and the pace of build are worth noting for a stock this size. Borrowing costs have eased alongside the trimming, now running at 1.17%, roughly 10% cheaper than a week ago and 31% cheaper than a month ago. Availability has loosened sharply too, rising from a 52-week low of 19.5% in late August to 135% now. That swing tells the clearest story: the borrow squeeze that characterised late August has fully unwound, and there is ample room in the lending pool for new short positions if sentiment sours again.
Options data adds almost nothing to the picture this week. The put/call ratio is zero, with only call activity recorded, and there is no 20-day history to provide context. That absence likely reflects thin options volume rather than a meaningful directional signal.
The bull and bear debate on Ethos is structural. Bulls point to proprietary technology and diversified carrier partnerships as the engine of margin expansion. Bears centre on the commission model: revenue is a function of carrier pricing and underwriting decisions that management cannot control, and any policy terminations can trigger clawbacks that hit cash flow directly. Valuation multiples have compressed over the past month. The price-to-earnings ratio has dropped roughly 2.5 points over 30 days to 14.4x, and price-to-book has fallen 0.6 points to 3.6x. EV/EBITDA has also eased, down about 0.9 points to 15.5x. The direction of travel is cheaper, but not dramatically so.
Insider activity is all planned sales, which reduces the signal strength considerably. Both CEO Peter Colis and President Lingke Wang filed under pre-arranged 10b5-1 plans in mid-September. Wang sold roughly $4.6 million of stock at prices between $38.36 and $39.67. Colis sold around $860,000 across multiple tranches at $35.98 to $37.52. Net insider sales over 90 days total approximately $11.7 million. The 10b5-1 structure means these were scheduled in advance, not discretionary reactions to the stock's recent weakness, but the scale of selling near what now looks like a short-term high is visible context for anyone tracking insider flow.
The ownership register is concentrated. SC US (TTGP), an entity connected to Sequoia, holds 27.8% as last disclosed. Co-founders Colis and Wang each hold around 17.5% to 17.6% individually. Accel sits at 18.1%. Alphabet Holdings filed a 13G/A in August, trimming slightly to 11.7% from 12.2%. All filings are passive 13G disclosures; there is no 13D activist on the register. Stakes are as-last-disclosed around the 5% threshold, and holders can drop below that level without filing again.
The prior two earnings prints produced outsized moves. The August 2026 report generated a 35% one-day gain and nearly 59% over the following five days. An earlier release produced a 7.8% one-day move with a 21% five-day follow-through. Both moves were to the upside. With November 3 now 27 days out, the key question heading into the print is whether the commission growth that drove those reactions has continued at a pace that justifies a stock now trading 10% below its post-earnings peak.
See the live data behind this article on ORTEX.
Open LIFE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.